Thousands of investors, millions in profit
Results 1 - 10 of 1076 : 1 2 3 4 5 6 7 8 9 Next
The Dow's 3 Biggest Losers This Week
Here they are.
Why the Dow Finished Higher This Week, and Facebook Didn't
An interesting week ends with the Dow slightly in the black.
The Meaningless Drug Approval That Could Cost the Industry Billions
Being able to use surrogate endpoints is important for drug developers.
3 Dow Stocks That Held the Average Down
These stocks were among the Dow's losers.
Will the Dow Break Its Losing Streak?
A brief look at the market's moves so far today.
5 Pharmaceutical Stocks With Significant Exposure to Europe
A fracture of the European monetary union could spell trouble for these five pharmaceutical stocks.
Drug Fails: At Least It's Approved Already
Pfizer's Torisel fails to best Nexavar in a head-to-head trial.
The Dow Couldn't Hold Back These 4 Stocks
These Dow stocks bucked a down market.
Why Greece Is Dragging Down the Dow
More pain ahead
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK